Orbis Allan Gray’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Buy
174,752
+1,171
+0.7% +$38.5K 0.02% 95
2026
Q1
$6.47M Sell
173,581
-26,664
-13% -$1.1M 0.03% 90
2025
Q4
$9.37M Sell
200,245
-14,287
-7% -$618K 0.04% 86
2025
Q3
$8.99M Sell
214,532
-145,168
-40% -$6.38M 0.04% 83
2025
Q2
$15.8M Sell
359,700
-1,146,777
-76% -$51.9M 0.08% 73
2025
Q1
$75.9M Sell
1,506,477
-302,065
-17% -$15M 0.43% 49
2024
Q4
$77.7M Buy
1,808,542
+69,483
+4% +$2.93M 0.42% 45
2024
Q3
$68.2M Buy
+1,739,059
New +$62.9M 0.36% 45

Other funds holding G

Orbis Allan Gray's G Position: Q2 2026 in Review

Orbis Allan Gray increased its Genpact (G) stake by 0.67% in Q2 2026, buying an estimated $38.5K and bringing the position to 174,752 shares worth $4.81M. The position accounts for 0.02% of the portfolio, ranked #95.

Orbis Allan Gray first reported a position in G in Q3 2024 and has held it in 8 quarters since. The position peaked at $77.7M in Q4 2024. 478 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Orbis Allan Gray held 174,752 shares of Genpact worth $4.81M as of Q2 2026.
  • Orbis Allan Gray bought 1,171 Genpact shares in Q2 2026, an estimated $38.5K.
  • Genpact made up 0.02% of Orbis Allan Gray's portfolio in Q2 2026, its #95 holding.
  • Orbis Allan Gray first reported a position in Genpact in Q3 2024 and has held it in 8 quarters since.
  • Orbis Allan Gray's Genpact position peaked at $77.7M in Q4 2024.
  • 478 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Orbis Allan Gray's 13F filing for Q2 2026, filed 14 Aug 2026.